The independent source for health policy research, polling, and news.
A Year of Crisis: How COVID-19 Upended the Election’s Focus on Health Care Policy—Or Did It?
In this post, Ashley Kirzinger and Mollyann Brodie examine how the COVID-19 pandemic and other crises shook up the mix of issues voters care about without changing the 2020 presidential race’s core dynamic as a referendum on President Trump’s first term in office.
Column Read PostWant to protect people with preexisting conditions? You need the full Affordable Care Act.
In this perspective published by the Washington Post, KFF Executive Vice President for Health Policy Larry Levitt explains why the popular Affordable Care Act provisions that ensure people with pre-existing conditions can access affordable health insurance can’t easily be preserved if other related provisions are overturned.
Op-Ed Read PostJoe Biden’s Big Lead on Health Care Issues
In an Axios column, Drew Altman discusses how this election year health isn’t a single issue — but several — and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Column Read PostBlack Americans Are More Skeptical of a Coronavirus Vaccine
Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.
Column Read PostDrugs Aren’t the Reason the U.S. Spends So Much on Health Care
Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.
Column Read PostWhat Will Candidates Say About Medicare This Election?
In this article for the American Society of Aging’s Generations Today, KFF Senior Vice President Tricia Neuman examines what President Trump and former Vice President Joe Biden are saying about key issues for Medicare beneficiaries, including drug prices and affordability, as well as what they aren’t saying about Medicare’s financing.
Column Read Post